SAGENT PHARMACE
Indication
Pemphigus
Pemphigus refers to a group of rare, chronic, life-threatening autoimmune blistering diseases that target stratified squamous epithelia, including the epidermis and mucous membranes. Read more about Pemphigus
335 drugs 162 manufacturers
Drugs that treat it
Common Pemphigus therapies.
SAGENT PHARMACE
READYSHARP DEXAMETHASONE (dexamethasone sodium phosphate)
DISSEMINATED TUBERCULOSIS·+60
TERRAIN PHARMAC
PREDNISONE
GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
QUALITEST/PAR P
PREDNISONE
GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
QUALITEST/PAR P
SOLU-CORTEF (hydrocortisone sodium succinate)
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+57
Pfizer Laboratories
SOLU-MEDROL (methylprednisolone sodium succinate)
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+52
Pfizer Laboratories
DEPO-MEDROL (methylprednisolone acetate)
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+43
Pfizer Laboratories
HYDROCORTISONE
TRICHINOSIS·+51
VENSUN PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Pemphigus preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPemphigus refers to a group of rare, chronic, life-threatening autoimmune blistering diseases that target stratified squamous epithelia, including the epidermis and mucous membranes.
It primarily affects adults and is characterized pathophysiologically by pathogenic IgG autoantibodies directed against desmogleins—principally desmoglein 1 and desmoglein 3—which are vital cell-to-cell adhesion molecules within desmosomes.
This autoimmune attack induces acantholysis, or the detachment of neighboring keratinocytes, resulting in intraepithelial clefting.
Clinically, this process manifests as fragile, flaccid bullae and extensive, painful mucosal and cutaneous erosions that leave patients susceptible to severe fluid loss and secondary systemic infections.
- nih.gov
Pemphigus refers to a group of rare, chronic, life-threatening autoimmune blistering diseases that target stratified squamous epithelia, including the epidermis and mucous membranes It primarily affects adults and is characterized pathophysiologically by pathogenic IgG autoantibodies directed against desmogleins—principally desmoglein 1 and desmoglein 3—which are vital cell-to-cell adhesion molecules within desmosomes This autoimmune attack induces acantholysis, or the detachment of neighboring ...
- nih.gov
Pemphigus refers to a group of rare, chronic, life-threatening autoimmune blistering diseases that target stratified squamous epithelia, including the epidermis and mucous membranes
- mayoclinic.org
Clinically, this process manifests as fragile, flaccid bullae and extensive, painful mucosal and cutaneous erosions that leave patients susceptible to severe fluid loss and secondary systemic infections
Personalize your experience
Follow Pemphigus and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.